Home › Bipolar Disorder › Massachusetts › Cambridge
Bipolar Disorder clinical trials in Cambridge, MA
5 studies for Bipolar Disorder are looking for participants at sites in and around Cambridge (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
Recruiting
- McLean Hospital, Belmont · 4 mi away
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
RecruitingHealthy volunteers welcome
- McLean Hospital, Belmont · 4 mi away
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
RecruitingPhase 2
- McLean Hospital, Belmont · 4 mi away
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
RecruitingObservational study
- McLean Hospital, Belmont · 4 mi away
Enhanced Coordinated Specialty Care for Early Psychosis
Recruiting
- Cambridge Health Alliance RISE Clinic, Cambridge
- McLean Hospital OnTrack Clinic, Belmont · 4 mi away
About Bipolar Disorder
Bipolar disorder is a mood disorder that can cause intense mood swings. It's also called manic depression. Learn about the types, symptoms, treatment, and more.
More about Bipolar Disorder on MedlinePlus
Bipolar Disorder trials in other cities
- Houston, TX10 studies
- New York City, NY7 studies
- Boston, MA7 studies
- Little Rock, AR6 studies
- Atlanta, GA6 studies
- Miami, FL5 studies
- Hialeah, FL5 studies
- Austin, TX5 studies
- Orange, CA5 studies
- Anaheim, CA4 studies
- Everett, WA4 studies
- West Palm Beach, FL4 studies
Other studies in Cambridge
- Schizophrenia8 studies
- Depression7 studies
- Psychotic Disorders6 studies
- Major Depressive Disorder6 studies
- Alzheimer's Disease6 studies
- Spinal Cord Injuries5 studies
- Anxiety4 studies
- Obsessive-Compulsive Disorder3 studies
- Mild Cognitive Impairment3 studies
- Phantom Limb3 studies
- Drug Use and Addiction3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.